Stockreport

Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement [Yahoo! Finance]

Callan JMB Inc.  (CJMB) 
PDF SPRING BRANCH, Texas, March 27, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics and operational infras [Read more]